{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:28:05Z","timestamp":1791862085699,"version":"4.3.4"},"reference-count":102,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Preclinical investigation and clinical experience have provided evidence on the potential anticancer effect of artemisinin and its derivatives (ARTs) in the recent two decades. The major mechanisms of action of ARTs may be due to toxic-free radicals generated by an endoperoxide moiety, cell cycle arrest, induction of apoptosis, and inhibition of tumor angiogenesis. It is very promising that ARTs are expected to be a new class of antitumor drugs of wide spectrum due to their detailed information regarding efficacy and safety. For developing repurposed drugs, many other characteristics of ARTs should be studied, including through further investigations on possible new pathways of anticancer effects, exploration on efficient and specific drug delivery systems-especially crossing biological barriers, and obtaining sufficient data in clinical trials. The aim of this review is to highlight these achievements and propose the potential strategies to develop ARTs as a new class of cancer therapeutic agents.<\/jats:p>","DOI":"10.3390\/molecules21101331","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T10:35:19Z","timestamp":1476095719000},"page":"1331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7596-6174","authenticated-orcid":false,"given":"Zhe","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"},{"name":"Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[{"name":"Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/0008-5472.CAN-13-1955","article-title":"Unbiased compound screening identifies unexpected drug sensitivitie sand novel treatment options for gastrointestinal stromal tumors","volume":"74","author":"Boichuk","year":"2014","journal-title":"Cancer. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCO.0000000000000098","article-title":"Aspirin in gastrointestinal oncology: New data on an old friend","volume":"26","author":"Langley","year":"2014","journal-title":"Curr. Opin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/CEJ.0000000000000098","article-title":"Aspirin and NSAIDs for breast cancer chemoprevention","volume":"24","author":"Yiannakopoulou","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_6","first-page":"E435","article-title":"Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK","volume":"111","author":"Liu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","first-page":"57","article-title":"Metformin in cancer prevention and therapy","volume":"2","author":"Kasznicki","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2014-05-576256","article-title":"Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction\/consolidation therapy for newly diagnosed multiple myeloma","volume":"125","author":"Sonneveld","year":"2015","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1634\/theoncologist.2014-0283","article-title":"Chronic thalidomide and chemoembolization for hepatocellular carcinoma","volume":"19","author":"Wu","year":"2014","journal-title":"Oncologist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3332\/ecancer.2014.485","article-title":"Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(79)91306-0","article-title":"Antitumour effect of cimetidine","volume":"1","author":"Armitage","year":"1979","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RAR\u03b1 oncoprotein by directly binding PML","volume":"328","author":"Zhang","year":"2010","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-14-0665-T","article-title":"Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursors","volume":"14","author":"Beauchamp","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_14","unstructured":"Collaboration Research Group for Qinghaosu (1977). A novel kind of sesquiterpene lactone-artemisinin. Chin. Sci. Bullet., 22, 142."},{"key":"ref_15","first-page":"129","article-title":"Structure and reaction of qinghaosu (Arteannuin)","volume":"37","author":"Liu","year":"1979","journal-title":"Acta. Chimica Sinica"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): An antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.actatropica.2016.08.006","article-title":"Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007\u20132015): In vivo response and dhfr and dhps mutations","volume":"164","author":"Kakar","year":"2016","journal-title":"Acta. Trop."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J. Nat. Prod."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization, and mechanisms of action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1582-4934.2008.00360.x","article-title":"Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy","volume":"13","author":"Chen","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wang, Y.B., Hu, Y., Li, Z., Wang, P., Xue, Y.X., Yao, Y.L., Yu, B., and Liu, Y.H. (2013). Artemether combined with shRNA interference of vascular cell adhesion molecule-1 significantly inhibited the malignant biological behavior of human glioma cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060834"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jat.1734","article-title":"In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100)","volume":"33","author":"Alcntara","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"ref_24","first-page":"139","article-title":"Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+T-reg cells in vivo","volume":"10","author":"Hassan","year":"2013","journal-title":"Iran J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","article-title":"Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer","volume":"70","author":"Ericsson","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"key":"ref_27","first-page":"937","article-title":"Structure of artemisilactone","volume":"48","author":"Zhu","year":"1984","journal-title":"Acta Chimica Sinica"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00280-010-1355-4","article-title":"In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents","volume":"67","author":"Gravett","year":"2011","journal-title":"Cancer Chemother Pharmacol."},{"key":"ref_29","first-page":"466","article-title":"Research advance in antitumor activities of artemisinin and its derivatives","volume":"35","author":"Yang","year":"2013","journal-title":"Zhong Guo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/138161209787315576","article-title":"Novel classes of dimer antitumour drug candidates","volume":"15","author":"Chow","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kong, R., Jia, G., Chen, Z.X., Wang, Y.W., Mu, M., Wang, S.J., Pan, S.H., Gao, Y., Jian, H.C., and Dong, D.L. (2012). Dihydroartemisinin enhances Apo2L\/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5. PLoS ONE, 7.","DOI":"10.1371\/annotation\/f7203563-87dc-4d11-a1b7-958f81cf743a"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","article-title":"Artesunateinduces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells","volume":"10","author":"Berdelle","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1074\/jbc.M110.144188","article-title":"The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials","volume":"286","author":"Mercer","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138945006776359412","article-title":"Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells","volume":"7","author":"Efferth","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2008.09.023","article-title":"Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis","volume":"274","author":"Nakase","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4161\/cbt.7.7.6035","article-title":"Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species","volume":"7","author":"Lu","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_37","first-page":"4389","article-title":"Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-\u03b1-phenylnitrone and deferoxamine","volume":"33","author":"Chan","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/CAD.0b013e328350e8ac","article-title":"Artesunate induces G0\/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells","volume":"23","author":"Jiang","year":"2012","journal-title":"Anticancer Drugs."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chen, G., Gong, R., Shi, X., Yang, D., Zhang, G., Lu, A., Yue, J., and Bian, Z. (2016). Halofuginone and artemisinin synergistically arrest cancer cells at the G1\/G0 phase by upregulating p21Cip1 and p27Kip1. Oncotarget.","DOI":"10.18632\/oncotarget.10367"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1074\/jbc.M804491200","article-title":"Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression","volume":"284","author":"Willoughby","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_41","first-page":"339","article-title":"Artesunate induces G2\/M cell cycle arrest through autophagy induction in breast cancer cells","volume":"91","author":"Chen","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"ref_42","first-page":"337","article-title":"Effects of artesunate on cytokinesis and G0\/M cell cycle progression of tumour cells and budding yeast","volume":"7","author":"Pereira","year":"2010","journal-title":"Cancer Geno. Proteom."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","article-title":"Dihydroartemisinin inactivates NF-\u03baB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo","volume":"293","author":"Wang","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1167\/iovs.12-11068","article-title":"The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells","volume":"54","author":"Cheng","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12185-009-0409-z","article-title":"Effect ofartesunateon inhibiting proliferation and inducing apoptosis of SP2\/0 myeloma cells through affecting NF-\u03baB p65","volume":"90","author":"Li","year":"2009","journal-title":"Int. J. Hematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.niox.2010.12.005","article-title":"Artesunatemitigates proliferation of tumor cells by alkylating heme-harboring nitric oxide synthase","volume":"24","author":"Zeng","year":"2011","journal-title":"Nitric Oxide"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"33425","DOI":"10.1074\/jbc.M114.564567","article-title":"Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin","volume":"289","author":"Yang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1002\/jcp.24086","article-title":"Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells","volume":"227","author":"Zhou","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production","volume":"286","author":"Stein","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-011-0716-6","article-title":"Anti-tumor effects of dihydroartemisinin on human osteosarcoma","volume":"351","author":"Ji","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejh.12176","article-title":"Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate","volume":"91","author":"Holien","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1745-7254.2007.00612.x","article-title":"Dihydroartemisinin is an inhibitor of ovarian cancer cell growth","volume":"28","author":"Jiao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00432-009-0731-0","article-title":"Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: Involvement of cell cycle arrest and inactivation of nuclear factor-\u03baB","volume":"136","author":"Chen","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bcp.2010.02.016","article-title":"Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells","volume":"80","author":"Lu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.bmc.2013.04.059","article-title":"Novel artemisinin derivatives with potential usefulness against liver\/colon cancer and viral hepatitis","volume":"21","author":"Blazquez","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","article-title":"Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin vitro\u201d replicative system","volume":"68","author":"Romero","year":"2005","journal-title":"Antiviral. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1358\/mf.2007.29.1.1063493","article-title":"Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells","volume":"29","author":"Mu","year":"2007","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00280-007-0517-5","article-title":"The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells","volume":"61","author":"Mu","year":"2008","journal-title":"Cancer Chemother Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-9966-33-8","article-title":"The activation of c-Jun NH2-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells","volume":"33","author":"Jia","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12936-016-1443-y","article-title":"In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin","volume":"15","author":"Njokah","year":"2016","journal-title":"Malar. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00280-011-1643-7","article-title":"Dihydroartemisin in inhibits angiogenesis in pancreatic cancer by targeting the NF-\u03baB pathway","volume":"68","author":"Wang","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4161\/15384047.2014.955728","article-title":"Dihydroartemisin in targets VEGFR2 via the NF-\u03baB pathway in endothelial cells to inhibit angiogenesis","volume":"15","author":"Dong","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3892\/etm.2014.1997","article-title":"Dihydroartemisin in inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase- independent pathway","volume":"8","author":"Guo","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_66","first-page":"1929","article-title":"Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1","volume":"35","author":"Saeed","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12185-010-0697-3","article-title":"Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells","volume":"92","author":"Chen","year":"2010","journal-title":"Int. J. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/156800909787314020","article-title":"The role of downstream signaling pathways of the epidermal growth factor receptor for artesunate\u2019s activity in cancer cells","volume":"9","author":"Konkimalla","year":"2009","journal-title":"Curr. Cancer Drug Targets."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.3390\/molecules161210556","article-title":"The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model","volume":"16","author":"Ma","year":"2011","journal-title":"Molecules"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.03.041","article-title":"Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of \u03b2-catenin and E-cadherin","volume":"588","author":"Li","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_71","first-page":"454783","article-title":"Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo","volume":"2013","author":"Krusche","year":"2013","journal-title":"Evid. Based Compl. Alternat. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/aps.2013.48","article-title":"Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish","volume":"34","author":"Ba","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/molecules15010040","article-title":"Severe embryotoxicity of artemisinin derivatives in experimental animals, but possibly safe in pregnant women","volume":"15","author":"Li","year":"2009","journal-title":"Molecules"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.reprotox.2016.08.003","article-title":"Clinical and non-clinical safety of artemisinin derivatives in pregnancy","volume":"65","author":"Gomes","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"ref_75","first-page":"1819","article-title":"Safety and efficacy field study of artesunate for dogs with non-resectable tumours","volume":"33","author":"Rutteman","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/AAC.46.3.821-827.2002","article-title":"Neurotoxic mode of action of artemisinin","volume":"46","author":"Schmuck","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_78","first-page":"1599","article-title":"Artesunate in the treatment of metastatic uveal melanoma-first experiences","volume":"14","author":"Berger","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_79","first-page":"121","article-title":"Application Value of Interventional Ultrasound in Treatment of Primary Hepatic","volume":"18","author":"Zhang","year":"2007","journal-title":"Mod. Diag. Treat."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3736\/jcim20080206","article-title":"Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: A randomized controlled trial","volume":"6","author":"Zhang","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1534735406295311","article-title":"Case report of a pituitary macro adenoma treated with artemether","volume":"5","author":"Singh","year":"2006","journal-title":"Integr. Cancer Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12936-016-1422-3","article-title":"The production and exportation of artemisinin-derived drugs in China: current status and existing challenges","volume":"15","author":"Huang","year":"2016","journal-title":"Malar. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.celrep.2014.02.042","article-title":"Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function","volume":"7","author":"Shen","year":"2014","journal-title":"Cell Rep."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ba, Q., Zhou, N., Duan, J., Chen, T., Hao, M., Yang, X., Li, J., Yin, J., Chu, R., and Wang, H. (2012). Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042703"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","article-title":"Artesunate derived from traditional Chinese medicine induces DNA damage and repair","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1039\/c3mb70342h","article-title":"Artemisinin rewires the protein interaction network in cancer cells: Network analysis, pathway identification, and target prediction","volume":"9","author":"Huang","year":"2013","journal-title":"Mol. Biosyst."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Ochiuz, L., Grigoras, C., Popa, M., Stoleriu, I., Munteanu, C., Timofte, D., Profire, L., and Grigoras, A.G. (2016). Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration. Molecules, 21.","DOI":"10.3390\/molecules21070858"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2013.05.019","article-title":"Preparation and optimization of transferrin-modified- artemether lipid nanospheres based on the orthogonal design of emulsion formulation and physically electrostatic adsorption","volume":"452","author":"Eltayeb","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2008-2231-22-44","article-title":"Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin","volume":"22","author":"Gharib","year":"2014","journal-title":"DARU J. Pharm. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10717544.2013.801047","article-title":"In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice","volume":"20","author":"Jin","year":"2013","journal-title":"Drug Deliv."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1556-276X-7-219","article-title":"An injectable hybrid nanoparticle-in-oil-in-water submicron emulsion for improved delivery of poorly soluble drugs","volume":"7","author":"Wang","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2014.03.044","article-title":"Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin","volume":"467","author":"Yang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/mp3002107","article-title":"LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics","volume":"9","author":"Wang","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.biomaterials.2014.04.028","article-title":"Multifunctional mesoporous nanoparticles as pH-responsive Fe2+ reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12272-014-0424-3","article-title":"Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-d,l-lactide-co-glycolide (PLGA) nanoparticles","volume":"38","author":"Nguyen","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11095-014-1545-6","article-title":"Nanoparticlesand the Blood-BrainBarrier: Advancing from in-Vitro Models towards Therapeutic Significance","volume":"32","author":"McCarthy","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1021\/nn501069c","article-title":"A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer","volume":"8","author":"Li","year":"2014","journal-title":"ACS Nano."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2014.08.003","article-title":"In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery","volume":"474","author":"Jose","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1642","article-title":"Creation and revelation: Two different routes to advancement in the biomedical sciences","volume":"13","author":"Goldstein","year":"2007","journal-title":"Nat. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Investig. New Drugs."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/2229-3485.76285","article-title":"Phase 0 clinical trials in oncology new drug development","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect. Clin. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.intimp.2011.08.017","article-title":"Artesunate enhances radio sensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2\/M phase","volume":"11","author":"Zhao","year":"2011","journal-title":"Int. Immunopharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/10\/1331\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:32:29Z","timestamp":1760211149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/10\/1331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":102,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"alternative-id":["molecules21101331"],"URL":"https:\/\/doi.org\/10.3390\/molecules21101331","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]}}}